📢#OARSI2023 will include a number of Discussion Groups. These meetings will bring together individuals with a focus on specific OA-related specialty areas.
More information here:
oarsi.org/membership/discuss…
Local and sustained release of the NSAID celecoxib supports long-term pain relief in dog #osteoarthritis 🐶🐶🐶
Read the #EditorsChoice paper chosen by @AM_Malf in the March issue of OAC
🔗 doi.org/10.1016/j.joca.2022.…
#OARSI2023 is less than two weeks away!
☕️🥐Sign up for a breakfast poster tour on Saturday or Sunday, 7:30 AM to 8:30 AM (additional fee). A tour guide will lead you through 8 different posters. Topics include Biology & Pathogenesis and Prevention & Rehabilitation.
Recommendations for the delivery of therapeutic exercise for people with hip or knee #osteoarthritis 🚶🏻♀️🏋️♀️
Read the #EditorsChoice chosen by @ProfDavidHunter in this month's issue of OAC
🔗 doi.org/10.1016/j.joca.2022.…
🔥🔥🔥POLL:
Very proud to be invited at the prestigious annual meeting of OARSI for a keynote lecture on what could explain so many failures in the development of disease-modifying osteoarthritis drugs in the recent years.
And for you, what are your 3 main reasons ?
Day One of #OARSI2023 will close with a Keynote Address: OA Research: Past and Future featuring Drs. Francis Berenbaum (@Larhumato) and Ian Wallace
🗓️Friday, March 17, 2023 - 6:30 PM to 7:30 PM
🏆#OARSI2023 Plenary Session 2 features the Highest Rated Abstracts from Early Career Investigators @OARSI_YI
Friday, March 17th 3:45 PM to 5:15 PM
⭐️The official #OARSI2023 program kicks off on Friday March 17th 1:45pm!⭐️
Opening Plenary Session 1: Emerging Therapeutics for OA
